Benitec Biopharma (BNTC) Equity Ratio: 2019-2025
Historic Equity Ratio for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to 3.02.
- Benitec Biopharma's Equity Ratio rose 293.79% to 3.02 in Q1 2025 from the same period last year, while for Mar 2025 it was 3.02, marking a year-over-year increase of 293.79%. This contributed to the annual value of 0.90 for FY2024, which is 1899.87% up from last year.
- Benitec Biopharma's Equity Ratio amounted to 3.02 in Q1 2025, which was down 15.19% from 3.56 recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Equity Ratio ranged from a high of 3.56 in Q4 2024 and a low of 0.05 during Q2 2023.
- Over the past 3 years, Benitec Biopharma's median Equity Ratio value was 0.82 (recorded in 2023), while the average stood at 1.26.
- Per our database at Business Quant, Benitec Biopharma's Equity Ratio slumped by 90.62% in 2023 and then surged by 1,899.87% in 2024.
- Over the past 5 years, Benitec Biopharma's Equity Ratio (Quarterly) stood at 0.77 in 2021, then fell by 2.30% to 0.76 in 2022, then fell by 4.10% to 0.72 in 2023, then skyrocketed by 391.41% to 3.56 in 2024, then soared by 293.79% to 3.02 in 2025.
- Its Equity Ratio was 3.02 in Q1 2025, compared to 3.56 in Q4 2024 and 0.93 in Q3 2024.